Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
or

Ascendis Pharma ADR (ASND)

Ascendis Pharma ADR (ASND)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
164.15 +3.70 (+2.31%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 164.15 unch (unch) 16:27 ET
Profile for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.

Company Info

Ascendis Pharma ADR TUBORG BOULEVARD 12 HELLERUP G7 2900 DNK

www.ascendispharma.com Employees: 1,017 P: 45-7022-2244

Sector:

Medical

Description:

Ascendis Pharma A/S is a biopharmaceutical company. The company's product pipeline consist of TransCon Human Growth Hormone, TransCon Treprostinil, TransCon Insulin, TransCon Peptide and TransCon Ranibizumab, which are in different clinical stage, for the treatments of hormone deficiency, endocrinology, central nervous system disorders, infectious diseases and diabetes. Its technology includes TransCon which develop prodrug therapies. Ascendis Pharma A/S is based in Denmark.

Key Statistics

Overview:

Market Capitalization, $K 10,008,389
Enterprise Value, $K 10,329,849
Shares Outstanding, K 60,971
Annual Sales, $ 393,500 K
Annual Net Income, $ -409,120 K
Last Quarter Sales, $ 187,020 K
Last Quarter Net Income, $ -39,990 K
EBIT, $ -301,650 K
EBITDA, $ -282,480 K
60-Month Beta 0.54
% of Insider Shareholders 40.00%
Float, K 36,583
% Float 60.00%
Short Volume Ratio 0.37

Growth:

1-Year Return 19.88%
3-Year Return 79.85%
5-Year Return 27.88%
5-Year Revenue Growth 2,526.84%
5-Year Earnings Growth -34.67%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.68 on 02/12/25
Next Earnings Date 05/01/25 [AMC]
Earnings Per Share ttm -7.10
EPS Growth vs. Prev Qtr 64.02%
EPS Growth vs. Prev Year 59.04%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ASND Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -39.23%
Profit Margin % -103.97%
Debt/Equity -8.10
Price/Sales 24.86
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.88
Interest Coverage -2.73
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective